港股異動丨貓眼娛樂升超5% 發佈文娛消費場景新業務疊加《葉問4》票房高漲
格隆匯12月24日丨貓眼娛樂(1896.HK)今日股價震盪走高,現升5.3%,報14.3港元,暫成交1219萬港元,最新總市值161.4億港元。

日前貓眼娛樂在京舉行媒體溝通會,發佈了全文娛戰略統籌下的新業務形態——文娛消費場景營銷。從單一的票務到電影的出品,再到現在全文娛戰略的佈局,貓眼實現從點到線再到面的發展。目前,已有1000多家影院及數十家品牌方與貓眼簽訂戰略合作協議。
據悉,《葉問》電影系列完結篇《葉問4》自上週五上映以來,連續多日位居單日票房榜冠軍,目前票房破3億元,也收穫了不錯的口碑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.